MEP11708A - Dimethoxy docetaxel acetone solvate et method for the preparation thereof - Google Patents

Dimethoxy docetaxel acetone solvate et method for the preparation thereof

Info

Publication number
MEP11708A
MEP11708A MEP-117/08A MEP11708A MEP11708A ME P11708 A MEP11708 A ME P11708A ME P11708 A MEP11708 A ME P11708A ME P11708 A MEP11708 A ME P11708A
Authority
ME
Montenegro
Prior art keywords
preparation
acetone solvate
dimethoxy
dimethoxy docetaxel
docetaxel acetone
Prior art date
Application number
MEP-117/08A
Other languages
Bosnian (bs)
English (en)
Croatian (hr)
Inventor
Eric Didier
Marc-Antoine Perrin
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34224354&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MEP11708(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of MEP11708A publication Critical patent/MEP11708A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
MEP-117/08A 2003-09-19 2004-09-16 Dimethoxy docetaxel acetone solvate et method for the preparation thereof MEP11708A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0311016A FR2859996B1 (fr) 2003-09-19 2003-09-19 Solvat acetonique du dimethoxy docetaxel et son procede de preparation
PCT/FR2004/002344 WO2005028462A1 (fr) 2003-09-19 2004-09-16 Solvat acetonique du dimethoxy docetaxel et son procede de preparation

Publications (1)

Publication Number Publication Date
MEP11708A true MEP11708A (en) 2010-06-10

Family

ID=34224354

Family Applications (2)

Application Number Title Priority Date Filing Date
MEP-2008-117A ME00054B (me) 2003-09-19 2004-09-16 Acetonski solvati dimetoksi docetaksela i postupci za njihovo dobijanje
MEP-117/08A MEP11708A (en) 2003-09-19 2004-09-16 Dimethoxy docetaxel acetone solvate et method for the preparation thereof

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MEP-2008-117A ME00054B (me) 2003-09-19 2004-09-16 Acetonski solvati dimetoksi docetaksela i postupci za njihovo dobijanje

Country Status (38)

Country Link
US (1) US7241907B2 (xx)
EP (1) EP1667986B1 (xx)
JP (1) JP5010279B2 (xx)
KR (1) KR101123588B1 (xx)
CN (1) CN100429207C (xx)
AR (1) AR045667A1 (xx)
AU (1) AU2004274212B2 (xx)
BE (1) BE2013C036I2 (xx)
BR (1) BRPI0414492A8 (xx)
CA (1) CA2539309A1 (xx)
CR (1) CR8292A (xx)
CY (2) CY1114575T1 (xx)
DK (1) DK1667986T3 (xx)
ES (1) ES2403149T4 (xx)
FR (1) FR2859996B1 (xx)
HK (1) HK1093340A1 (xx)
HR (1) HRP20130322T1 (xx)
HU (1) HUS1300025I1 (xx)
IL (1) IL174240A (xx)
LU (1) LU92172I2 (xx)
MA (1) MA28045A1 (xx)
ME (2) ME00054B (xx)
MX (1) MXPA06002639A (xx)
MY (1) MY136668A (xx)
NO (2) NO335997B1 (xx)
NZ (1) NZ545835A (xx)
PA (1) PA8612401A1 (xx)
PE (1) PE20050870A1 (xx)
PL (1) PL1667986T3 (xx)
PT (1) PT1667986E (xx)
RS (2) RS54614B1 (xx)
RU (1) RU2342373C2 (xx)
SI (1) SI1667986T1 (xx)
TN (1) TNSN06086A1 (xx)
TW (1) TWI382022B (xx)
UA (1) UA87115C2 (xx)
WO (1) WO2005028462A1 (xx)
ZA (1) ZA200602255B (xx)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080100264A (ko) * 2006-03-21 2008-11-14 닥터 레디스 레보러터리즈 리미티드 도세탁셀의 다형체와 그 제조방법
US7855591B2 (en) * 2006-06-07 2010-12-21 Atmel Corporation Method and system for providing a charge pump very low voltage applications
US7652522B2 (en) * 2006-09-05 2010-01-26 Atmel Corporation High efficiency low cost bi-directional charge pump circuit for very low voltage applications
JP2010516625A (ja) 2007-01-24 2010-05-20 インサート セラピューティクス， インコーポレイテッド 制御された薬物送達のためのテザー基を有するポリマー−薬物コンジュゲート
AU2013205442B2 (en) * 2008-01-17 2016-05-12 Aventis Pharma S.A. Crystalline forms of dimethoxy docetaxel and methods for preparing same
FR2926551A1 (fr) * 2008-01-17 2009-07-24 Aventis Pharma Sa Formes cristallines du dimethoxy docetaxel et leurs procedes de preparation
CA2732508C (en) 2008-08-11 2016-03-15 Nektar Therapeutics Multi-arm polymeric alkanoate conjugates
FR2945211A1 (fr) * 2009-05-06 2010-11-12 Sanofi Aventis Combinaison antitumorale comprenant la cabazitaxel et la capecitabine
PE20121429A1 (es) 2009-10-29 2012-11-06 Aventis Pharma Sa Nuevo uso antitumoral de cabazitaxel
AU2015200149B2 (en) * 2009-10-29 2016-12-01 Aventis Pharma S.A. Novel antitumoral use of cabazitaxel
CA2708489A1 (en) * 2009-10-29 2011-04-29 Aventis Pharma S.A. Use of cabazitaxel and a prednisone or a prednisolone in the treatment of prostate cancer
WO2012088422A1 (en) 2010-12-22 2012-06-28 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of taxane-based compounds
WO2012088445A1 (en) 2010-12-22 2012-06-28 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
ES2621800T3 (es) 2011-04-12 2017-07-05 Teva Pharmaceuticals International Gmbh Formas de estado sólido de cabazitaxel y procesos de preparación de las mismas
WO2013024495A1 (en) * 2011-08-18 2013-02-21 Dr. Reddys Laboratories Limited Pharmaceutical formulations of cabazitaxel
TWI526437B (zh) * 2011-09-09 2016-03-21 台灣神隆股份有限公司 卡巴他賽之結晶型
US8722900B2 (en) 2011-10-31 2014-05-13 Scinopharm Taiwan, Ltd. Process for cabazitaxel, and intermediates thereof
EP2773629B1 (en) 2011-11-01 2018-04-11 Fresenius Kabi Oncology Limited Process for the preparation of an amorphous form of cabazitaxel
CN104011035A (zh) * 2011-11-28 2014-08-27 费森尤斯卡比肿瘤学有限公司 卡巴他赛的晶型和用于制备其的方法
EP2791122B1 (en) 2011-12-13 2019-01-23 Aventis Pharma S.A. Crystalline form of cabazitaxel and process for preparing the same
US9403785B2 (en) 2012-01-03 2016-08-02 Shilpa Medicare Limited Process for preparing amorphous cabazitaxel
JP2015509929A (ja) * 2012-02-10 2015-04-02 アベンティス・ファーマ・ソシエテ・アノニム カバジタキセルの新規な小児への使用
WO2013134534A2 (en) 2012-03-08 2013-09-12 Plus Chemicals S.A. Solid state forms of cabazitaxel and processes for preparation thereof
CN102675257B (zh) * 2012-05-10 2014-07-02 上海金和生物技术有限公司 一种卡巴他赛晶体及其制备方法
CN102746258B (zh) 2012-07-25 2015-02-04 重庆泰濠制药有限公司 卡巴他赛的结晶形式及其制备方法
EP2880021A4 (en) 2012-07-31 2015-06-17 Yung Shin Pharm Ind Co Ltd AMORPHIC CABACITAXEL
EP2884963B1 (en) 2012-08-15 2017-12-27 Yung Shin Pharm. Ind. Co. Ltd. Stable pharmaceutical formulation of cabazitaxel
CN103664836B (zh) * 2012-09-20 2016-04-20 齐鲁制药有限公司 7β,10β-二甲氧基多西紫杉醇氘代丙酮合物的晶型A及其制备方法
WO2014055493A1 (en) 2012-10-02 2014-04-10 Cerulean Pharma Inc. Methods and systems for polymer precipitation and generation of particles
CN103804323A (zh) * 2012-11-14 2014-05-21 上海希迈医药科技有限公司 一种卡巴他赛溶剂化物及其制备方法和应用
CN103058960B (zh) * 2012-12-12 2014-12-10 江苏奥赛康药业股份有限公司 卡巴他赛多晶型形式及其制备方法
EP2743264A1 (en) 2012-12-13 2014-06-18 INDENA S.p.A. New crystalline form of cabazitaxel, process for the preparation and pharmaceutical compositions thereof
CN103910696B (zh) * 2012-12-30 2016-01-20 上海医药工业研究院 卡巴他赛异丙醚合物及其结晶
CN103910698B (zh) * 2012-12-30 2016-01-20 上海医药工业研究院 卡巴他赛丙酮合物及其结晶
EP2777691A1 (en) 2013-03-14 2014-09-17 Pharmachemie B.V. Taxoid - Purification of Liquid Excipients
EP2815749A1 (en) 2013-06-20 2014-12-24 IP Gesellschaft für Management mbH Solid form of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione having specified X-ray diffraction pattern
CN104277014A (zh) * 2013-07-04 2015-01-14 北京新天宇科技开发有限公司 二甲氧基多西紫杉醇一丙酮化物的稳定转化物及其结晶形式、以及它们的制备方法
WO2015000165A1 (zh) * 2013-07-04 2015-01-08 北京新天宇科技开发有限公司 二甲氧基多西紫杉醇一丙酮化物的稳定转化物及其结晶形式、以及它们的制备方法
EP2865675A1 (en) 2013-10-23 2015-04-29 INDENA S.p.A. A crystalline anhydrous form of Cabazitaxel, process for the preparation and pharmaceutical compositions thereof
EP2865674A1 (en) 2013-10-23 2015-04-29 INDENA S.p.A. Crystalline solvate forms of Cabazitaxel
CN103601704B (zh) * 2013-11-22 2015-05-06 石家庄智恒医药科技有限公司 无定形卡巴他赛的制备
EP3247350B1 (en) 2015-01-12 2021-12-22 Emcure Pharmaceuticals Limited Liquid formulation of cabazitaxel
PT3258931T (pt) * 2015-02-17 2020-09-23 Univ Erasmus Med Ct Rotterdam Utilização do cabazitaxel no tratamento do cancro da próstata
EP3093014A1 (en) * 2015-05-13 2016-11-16 Aventis Pharma S.A. Cabazitaxel and its use for treating cancer
US10188626B2 (en) 2015-11-03 2019-01-29 Cipla Limited Stabilized cabazitaxel formulations
IL266955B2 (en) 2016-11-29 2023-09-01 Ptc Therapeutics Mp Inc Polymorphs of spiafatrin and its salts
CN110312721A (zh) 2016-11-29 2019-10-08 显莎制药公司 墨蝶呤的多晶型物
CA3073957A1 (en) 2017-09-01 2019-03-07 Censa Pharmaceuticals Inc. Pharmaceutical compositions comprising sepiapterin and uses thereof
AU2019277382A1 (en) 2018-05-30 2021-01-21 Ptc Therapeutics Mp, Inc. Methods for increasing sepiapterin plasma exposure
WO2020249507A1 (en) 2019-06-11 2020-12-17 Indena S.P.A. Anhydrous crystalline form of cabazitaxel, a process for its preparation and pharmaceutical compositions containing it
EP3808345A1 (en) 2019-10-15 2021-04-21 Sanofi Mature IP Cabazitaxel in mcrpc patients previously treated with docetaxel and who failed a prior androgen signaling targeted inhibitor agent
EP3797834A1 (en) 2019-09-25 2021-03-31 Sanofi Mature IP Cabazitaxel in mcrpc patients previously treated with docetaxel and who failed a prior androgen signaling targeted inhibitor agent

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5766635A (en) * 1991-06-28 1998-06-16 Rhone-Poulenc Rorer S.A. Process for preparing nanoparticles
MA23823A1 (fr) * 1995-03-27 1996-10-01 Aventis Pharma Sa Nouveaux taxoides, leur preparation et les compositions qui les contiennent
FR2745814B1 (fr) * 1996-03-06 1998-04-03 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2771092B1 (fr) 1997-11-18 1999-12-17 Rhone Poulenc Rorer Sa Procede de preparation de derives de la classe des taxoides
EP0982027A1 (en) * 1998-08-17 2000-03-01 Aventis Pharma S.A. Taxoid derivatives for treating abnormal cell proliferation of the brain
US6346543B1 (en) * 1998-08-17 2002-02-12 Aventis Pharma S.A. Use of a taxoid to treat abnormal cell proliferation in the brain
US6136989A (en) * 1998-12-30 2000-10-24 Phytogen Life Sciences, Incorporated Method for high yield and large scale extraction of paclitaxel from paclitaxel-containing material
US5969165A (en) * 1999-01-07 1999-10-19 508037 (Nb) Inc. Isolation and purification of paclitaxel and other related taxanes by industrial preparative low pressure chromatography on a polymeric resin column
JP2002544269A (ja) * 1999-05-17 2002-12-24 ブリストル−マイヤーズ スクイブ カンパニー パクリタキセルおよびパクリタキセル類似体の製造におけるシリルエーテルの切断のための新規反応条件
EP1457492B1 (en) * 2001-11-29 2008-01-02 Daiichi Sankyo Company, Limited Crystals of taxane derivative and process for their production

Also Published As

Publication number Publication date
FR2859996A1 (fr) 2005-03-25
AR045667A1 (es) 2005-11-02
US7241907B2 (en) 2007-07-10
CN1849311A (zh) 2006-10-18
DK1667986T3 (da) 2013-05-06
PL1667986T3 (pl) 2013-06-28
PA8612401A1 (es) 2005-08-04
RS20060189A (xx) 2008-06-05
EP1667986B1 (fr) 2013-01-16
US20050065138A1 (en) 2005-03-24
CY2013016I1 (el) 2018-01-10
EP1667986A1 (fr) 2006-06-14
NO20061714L (no) 2006-04-19
JP2007505866A (ja) 2007-03-15
BRPI0414492A (pt) 2006-11-14
CN100429207C (zh) 2008-10-29
RU2006113122A (ru) 2006-08-27
TWI382022B (zh) 2013-01-11
IL174240A (en) 2010-12-30
NZ545835A (en) 2009-10-30
ME00054B (me) 2011-02-10
NO2015013I1 (no) 2015-05-04
FR2859996B1 (fr) 2006-02-03
CY1114575T1 (el) 2016-10-05
ZA200602255B (en) 2007-07-25
AU2004274212A1 (en) 2005-03-31
JP5010279B2 (ja) 2012-08-29
ES2403149T4 (es) 2013-06-24
CR8292A (es) 2008-10-15
BE2013C036I2 (xx) 2023-12-14
SI1667986T1 (sl) 2013-05-31
WO2005028462A1 (fr) 2005-03-31
LU92172I2 (fr) 2013-05-21
BRPI0414492A8 (pt) 2019-01-15
TW200524891A (en) 2005-08-01
NO335997B1 (no) 2015-04-20
HK1093340A1 (en) 2007-03-02
TNSN06086A1 (en) 2007-10-03
KR101123588B1 (ko) 2012-03-22
AU2004274212B2 (en) 2010-03-04
MY136668A (en) 2008-11-28
ES2403149T3 (es) 2013-05-14
MXPA06002639A (es) 2006-06-05
HUS1300025I1 (hu) 2016-08-29
HRP20130322T1 (xx) 2013-07-31
NO2015013I2 (no) 2015-04-22
CY2013016I2 (el) 2018-01-10
IL174240A0 (en) 2006-08-01
MA28045A1 (fr) 2006-07-03
PE20050870A1 (es) 2005-11-21
RS54614B1 (en) 2016-08-31
PT1667986E (pt) 2013-04-24
KR20060072147A (ko) 2006-06-27
LU92172I9 (xx) 2019-01-03
RU2342373C2 (ru) 2008-12-27
UA87115C2 (ru) 2009-06-25
CA2539309A1 (fr) 2005-03-31

Similar Documents

Publication Publication Date Title
MEP11708A (en) Dimethoxy docetaxel acetone solvate et method for the preparation thereof
BRPI0818672A2 (pt) 2'-fluor-2'-desoxitetra-hidrouridinas como inibidores da citidina desaminase
CY1116373T1 (el) Φαρμακευτικα σκευασματα που περιεχουν μεθυλναλτρεξονη
MX2009003958A (es) Nuevos derivados de 1,4-benzotiepina-1,1-dioxido sustituidos con radicales bencilo, metodo para su preparacion, productos farmaceuticos que comprenden estos compuestos y su uso.
BR112021025928A2 (pt) Métodos de preparação de ácido bempedoico e composições do mesmo
CY1108529T1 (el) Νεα αζαδικυκλικα παραγωγα, μεθοδος παρασκευης τους και φαρμακευτικες συνθεσεις που τα περιεχουν
ATE284388T1 (de) Cyclpentanoindole, mischungen derartige verbindungen enthaltend und behandlungsmethoden
CY1108067T1 (el) Υποκατεστημενα παραγωγα 2-πυριδινο-κυκλοεξανο-1,4-διαμινης
EA200601555A1 (ru) Замещенные индазол-о-глюкозиды
EA200601554A1 (ru) Замещенные индол-о-глюкозиды
CY1110738T1 (el) Παραγωγα aminoαλκυλβενζοϋλ-βενζοφουραν ή βενζοθειοφαιν, μεθοδος παρασκευης τους και συνθεσεις που τα περιεχουν
CY1110258T1 (el) Υποκατεστημενα παραγωγα c-κυκλοεξυλομεθυλαμινης
PT1246809E (pt) Compostos de 5-aril-1h-1,2,4-triazole como inibidores de ciclooxigenase-2 e composicoes farmaceuticas que os contem
EA201000329A1 (ru) Циклические депсипептиды
ATE468317T1 (de) Herstellung von 1,3-diphenylprop-2-en-1- onderivaten
EA200600694A1 (ru) Дисульфидные, сульфидные, сульфоксидные и сульфоновые производные циклических сахаров и их применение
CY1105275T1 (el) Ενωσεις υποκατεστημενης γ-λακτονης ως ανταγωνισται - νμda
BRPI0408389A (pt) derivados de cromeno como agentes antiinflamatórios
DE60316128D1 (de) N-sulfonylurea-apoptosis-förderer
FR2894579B1 (fr) Derives diaryltriazolmethylamine, leur preparation et leur application en therapeutique.
ATE419242T1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
BR0201237A (pt) Processo de obtenção de lignanas dibenzilbutirolactÈnicas, processo de obtenção de derivados sintéticos de lignanas ostentando atividades quimioprofilática e terapêutica antichagásica
EA200300063A1 (ru) Производные аминоалкенилбензоил-бензофурана или бензотиофена, способы их получения и содержащие их композиции
CY1111290T1 (el) Παραγωγα 9-αλκυλαμινo-1-νιτρoακριδινης
CY1108865T1 (el) Υποκατεστημενες 2,5-διαμινομευθυλο-1η-πυρρολες